Jul 6, 2026 09:30AM
Jun 26, 2026 09:43AM
Jun 26, 2026 09:42AM
May 12, 2026 04:00PM
May 12, 2026 04:00PM
May 5, 2026 05:11PM
Mar 19, 2026 04:01PM Curis reports Q4 2025 results, raises $20.2 million in financing
Mar 19, 2026 04:00PM
Mar 12, 2026 04:27PM
Jan 9, 2026 08:00AM
Jan 9, 2026 08:00AM
Jan 7, 2026 08:45AM
Jan 7, 2026 08:45AM
Dec 9, 2025 08:00AM Curis Provides Updated Data from its Frontline AML Triplet Study
Nov 14, 2025 09:26AM
Nov 6, 2025 04:00PM
Nov 6, 2025 04:00PM
Oct 30, 2025 04:00PM
Oct 3, 2025 04:00PM
Sep 2, 2025 10:43AM
Aug 5, 2025 08:02AM Curis reports narrowed Q2 loss, advances emavusertib studies
Aug 5, 2025 08:00AM
Jul 29, 2025 08:30AM
Jul 2, 2025 08:33AM
Jul 2, 2025 08:32AM
May 6, 2025 06:16PM
May 6, 2025 08:00AM
Apr 29, 2025 08:00AM Curis to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2025
Apr 2, 2025 04:05PM
Apr 1, 2025 06:47AM
Mar 31, 2025 08:01AM
Mar 31, 2025 08:00AM
Mar 28, 2025 04:07PM
Dec 10, 2024 08:13AM
Dec 10, 2024 08:00AM Curis Announces Additional Data from TakeAim Leukemia Study
Nov 14, 2024 08:01AM
Nov 14, 2024 08:00AM
Nov 7, 2024 08:00AM
Oct 29, 2024 06:06AM
Oct 29, 2024 06:04AM
Sep 27, 2024 01:59PM
Sep 23, 2024 08:30AM Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer
Sep 17, 2024 07:30AM
Sep 4, 2024 08:00AM
Aug 1, 2024 08:00AM
Jul 25, 2024 08:00AM
Jul 10, 2024 07:30AM
Jul 8, 2024 07:30AM
May 14, 2024 04:00PM Curis (CRIS) Announces Additional Data from TakeAim Leukemia Study
May 14, 2024 04:00PM

325,450 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All